P02768 (ALBU_HUMAN) Homo sapiens (Human)
Albumin UniProtKBInterProSTRINGInteractive Modelling
Available Structures
164 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Ternary complex of FcRn ectodomain, FcRn binding optimised human serum albumin and the human growth… |
Heteromer P55899; P61769; | 99.31 | 1×MES; 2×CYS; 1×JG5; | |||
| Crystal structure of a high affinity Human Serum Albumin variant bound to the Neonatal Fc Receptor |
Heteromer P55899; P61769; | 99.31 | 11×SO4; | |||
| Crystal structure of Nb.b201 bound to human serum albumin |
Heteromer | 100 | 3×GOL; 1×PLM; 1×DAO; | |||
| Human FcRn complexed with human serum albumin |
Heteromer P55899; P61769; | 100 | ||||
| Ternary complex between Neonatal Fc receptor, serum albumin and Fc |
Heteromer P01857; P55899; P61769; | 100 | 2×NAG; | |||
| Crystal structure of human serum albumin in complex with ALB8(VHH) domain of ozoralizumab |
Heteromer | 100.0 | ||||
| Ternary complex of FcRn ectodomain, FcRn binding optimised human serum albumin and the albumin-bini… |
Heteromer P55899; P61769; | 99.31 | 1×MES; 1×JG5; 1×BME; 1×CYS; | |||
| Crystal structure of plasma-derived human serum albumin |
Heteromer | 100 | 3×EIC; 5×OCA; 4×PLM; 3×TRP; 19×SO4; 13×PEG; 4×PGE; 5×PG4; 1×1PE; | |||
| Crystal structure of human serum albumin in complex with the MCL-1 neutralizing Alphabody CMPX-383B |
Heteromer | 99.46 | ||||
| Structure of human serum albumin with S-naproxen and the GA module |
Heteromer Q51911; | 100.0 | 6×DKA; 1×NPS; | |||
| Extending the half-life of a Fab fragment through generation of a humanised anti-Human Serum Albumi… |
Heteromer | 100 | ||||
| Crystal structure of a complex between human serum albumin and the antibody Fab SL335 |
Heteromer | 100.0 | ||||
| Crystal structure of Alb1 megabody in complex with human serum albumin |
Heteromer | 100.0 | ||||
| Solution structure of the complex between immunoglobulin IgA1 and human serum albumin |
Heteromer P01876; | 100 | ||||
| Crystal structure of the GA module complexed with human serum albumin |
Heteromer Q51911; | 100.0 | 3×DKA; 1×CIT; | |||
| Shark IgNAR variable domain |
Heteromer | 100.0 | ||||
| Shark IgNAR Variable Domain |
Heteromer | 100.0 | 1×EDO; 1×ACE; | |||
| Crystal Structure of Human serum albumin complexed with Lidocaine | homo-2-mer | 100 | 1×LQZ; | |||
| Crystal structure of Human Serum Albumin in complex with FESAN | monomer | 100 | 1×UZC; 2×DMS; 3×MYR; 1×GOL; 3×OCA; 4×SO4; | |||
| Crystal structure of the HSA Fe complex | monomer | 100 | 1×GOL; 1×9IZ; 5×FE; 7×PLM; 4×DMS; 16×CL; | |||
| Human Serum Albumin with Cobalt (II) and Myristic Acid - crystal 1 | monomer | 100 | 4×CO; 10×MYR; | |||
| Human Serum Albumin with Cobalt (II) and Myristic Acid - crystal 3 | monomer | 100 | 5×CO; 9×MYR; | |||
| CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN (HSA) IN COMPLEX WITH GN-07. | monomer | 100.0 | 6×MYR; 1×OQ5; | |||
| X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME | monomer | 100 | 5×MYR; 1×HEM; | |||
| X-ray study of human serum albumin complexed with 9 amino camptothecin | monomer | 100 | 5×MYR; 1×9AZ; | |||
| Crystal Structure Analysis of Human serum albumin complexed with delta 12-prostaglandin J2 | monomer | 100.0 | 6×MYR; 2×PJ2; | |||
| Crystal structure of human serum albumin and ruthenium PZA complex adduct | monomer | 100 | 5×PLM; 1×NO; 2×PZA; 2×RU; 3×CL; | |||
| Human Serum Albumin Complexed With Myristic Acid and the R-(+) enantiomer of warfarin | monomer | 100 | 6×MYR; 1×RWF; | |||
| Human Serum Albumin Complexed With Myristic Acid and the S-(-) enantiomer of warfarin | monomer | 100 | 6×MYR; 1×SWF; | |||
| Structure of Human serum albumin-Au compound complex | monomer | 100 | 6×PAM; 1×J2O; | |||
| Crystal structure of Human Serum Albumin in complex with ketoprofen | monomer | 100 | 1×CYS; 3×MYR; 3×9KL; 1×EDO; 1×JGE; | |||
| X-ray study of human serum albumin complexed with etoposide | monomer | 100 | 4×MYR; 1×EVP; | |||
| Human Serum Albumin with Cobalt (II) and Myristic Acid - crystal 2 | monomer | 100 | 9×CO; 3×MYR; | |||
| Crystal structure of human serum albumin crystallized by ammonium sulfate | monomer | 100 | ||||
| Structure of Human Serum Albumin in complex with Myristic Acid | monomer | 100 | 8×MYR; 1×EDO; | |||
| Structure of Human Serum Albumin in complex with Aristolochic Acid I at 1.9 A resolution - Optimized | monomer | 100 | 6×MYR; 1×EDO; 1×GOQ; | |||
| Structure of Human Serum Albumin in complex with Aristolochic Acid at 1.9 A resolution | monomer | 100 | 7×MYR; 2×EDO; | |||
| Structure of Human Serum Albumin in complex with Aristolochic Acid II at 1.9 A resolution | monomer | 100 | 6×MYR; 3×EDO; 2×GOR; | |||
| Human Serum Albumin Bound to Cerastecin Compound 5e | monomer | 100 | 6×MYR; 1×A1AZR; | |||
| Computational design of stable mammalian serum albumins for bacterial expression | monomer | 97.25 | 4×MYR; 1×RWF; | |||
| Recombinant human serum albumin from transgenic plant | monomer | 100 | 8×MYR; | |||
| Crystal structure of Human Serum Albumin complex with JMS-053 | monomer | 100 | 4×MYR; 1×UAY; 1×PG4; 1×OCA; 1×UNL; 2×EDO; | |||
| Human serum albumin-myristate-amantadine hydrochloride complex | monomer | 100 | 6×MYR; | |||
| Crystal structure of human serum albumin in complex with phosphorodithioate derivative of myristoyl… | monomer | 100 | 3×6A4; 2×PGE; 2×PEG; | |||
| Recombinant human serum albumin with palmitic acid. Synthetic cationic antimicrobial peptides bind … | monomer | 100 | 7×PLM; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH cis-9-OCTADECENOIC ACID (OLEIC ACID) | monomer | 100 | 7×OLA; | |||
| Human serum albumin complexed with myristate, azapropazone and indomethacin | monomer | 99.83 | 6×MYR; 1×IMN; 1×AZQ; | |||
| Human serum albumin complexed with dansyl-L-asparagine and myristic acid | monomer | 99.83 | 6×MYR; 2×9DN; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID and the general anesthetic halothane | monomer | 100 | 5×MYR; 7×HLT; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) and myristic acid (t… | monomer | 100 | 7×MYR; 1×T44; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID) | monomer | 100 | 8×DAO; | |||
| Crystal structure of lysophosphatidylcholine in complex with human serum albumin | monomer | 100 | 6×LPC; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID (CAPRIC ACID) | monomer | 100 | 10×DKA; | |||
| Human serum albumin complexed with myristate and azapropazone | monomer | 99.83 | 5×MYR; 2×AZQ; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID | monomer | 100 | 5×MYR; | |||
| Human serum albumin complexed with myristate and indomethacin | monomer | 100 | 7×MYR; 2×IMN; | |||
| Human serum albumin complexed with tetradecanoic acid (myristic acid) | monomer | 100 | 8×MYR; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH cis-5,8,11,14-EICOSATETRAENOIC ACID (ARACHIDONIC ACID) | monomer | 100 | 8×ACD; | |||
| Human serum albumin complexed with myristate and oxyphenbutazone | monomer | 100 | 6×MYR; 2×OPB; | |||
| Human serum albumin complexed with myristate, phenylbutazone and indomethacin | monomer | 99.83 | 6×MYR; 2×IMN; 1×P1Z; | |||
| Human serum albumin complexed with myristate and AZT | monomer | 100 | 7×MYR; 2×AZZ; | |||
| Structure of human serum albumin in complex with DAUDA | monomer | 100.0 | 4×MYR; 2×11D; | |||
| Human serum albumin complexed with dansyl-L-arginine and myristic acid | monomer | 99.83 | 6×MYR; 2×9NR; | |||
| Human serum albumin complexed with myristate and iodipamide | monomer | 100 | 6×MYR; 2×IDB; | |||
| Human serum albumin complexed with dansyl-L-glutamate and myristic acid | monomer | 99.83 | 6×MYR; 2×9NE; | |||
| HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) and myr… | monomer | 99.83 | 7×MYR; 1×T44; | |||
| Human serum albumin complexed with myristate and aspirin | monomer | 100 | 5×MYR; 1×SAL; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID (STEARIC ACID) | monomer | 100 | 7×STE; | |||
| Human serum albumin complexed with myristate, 3'-azido-3'-deoxythymidine (AZT) and salicylic acid | monomer | 100 | 6×MYR; 1×AZZ; 2×SAL; | |||
| Human serum albumin (HSA) crystallized in the presence of yttrium (III) chloride | monomer | 99.83 | 2×YT3; | |||
| Crystal Structure of Human serum albumin complexed with Myristic acid and lysophosphatidylethanolam… | monomer | 100 | 5×MYR; 1×LPX; | |||
| Human serum albumin complexed with myristate and salicylic acid | monomer | 100 | 2×SAL; 5×MYR; | |||
| X-ray structure of HSA-Myr-KP1019 | monomer | 100 | 2×RU; 6×MYR; | |||
| Human Serum Albumin | monomer | 100.0 | ||||
| HSA-Cu agent complex | monomer | 100 | 6×PLM; 2×IC4; | |||
| Human serum albumin-Palmitic acid-Cu compound | monomer | 100 | 6×PLM; 1×E5O; | |||
| Crystal structure of Human serum albumin in complex with perfluorooctanoic acid (PFOA) at 2.10 Angs… | monomer | 100 | 4×8PF; 1×MPO; 1×PGE; 1×PG4; 4×MYR; 6×MPD; 1×EDO; | |||
| Crystal structure of human serum albumin and ruthenium Val complex adduct | monomer | 100 | 1×NO; 1×VAL; 1×CL; 1×RU; 6×PLM; 2×GOL; 4×DMS; | |||
| Human serum albumin complexed with palmitic acid and diclofenac | monomer | 100 | 3×F15; 2×PLM; 3×DIF; | |||
| Crystal structure of Human Serum albumin in complex with Gemfibrozil | monomer | 100 | 2×MYR; 2×4TX; 1×PGE; 1×PG4; 6×MPD; 1×PO4; | |||
| Crystal structure of Human Serum Albumin in complex with surfactant GenX (2,3,3,3-tetrafluoro-2-(he… | monomer | 100 | 2×IGB; 6×MPD; 4×MYR; 1×BR; | |||
| Crystal structure of Human serum albumin in complex with myristic acid at 2.27 Angstrom Resolution | monomer | 100 | 6×MYR; 5×MPD; 1×FMT; 1×PO4; | |||
| Human serum albumin complexed with myristate and phenylbutazone | monomer | 100 | 7×MYR; 1×P1Z; | |||
| Crystal structure analysis of Human Serum Albumin in complex with chloride anions at cryogenic temp… | monomer | 100 | 3×CL; | |||
| Crystal structure of human serum albumin complex with aripiprazole and myristic acid | monomer | 100.0 | 6×MYR; 1×9SC; | |||
| human Serum Albumin complexed with NBD-C12 fatty acid | monomer | 100.0 | 2×C7K; | |||
| X-ray study of human serum albumin complexed with bicalutamide | monomer | 100 | 1×198; | |||
| Crystal structure of human serum albumin and nitrosylruthenium complex adduct | monomer | 100 | 2×RU; 1×HZQ; 7×CL; 2×NO; 4×GOL; 1×DMS; 5×PLM; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID (PALMITIC ACID) | monomer | 100 | 7×PLM; | |||
| Human serum albumin-palladium(II) agent complex | monomer | 100 | 6×PLM; 1×U5U; | |||
| HSA-Palmitic acid-[RuCl5(ind)]2- | monomer | 100 | 6×PLM; 2×7GE; | |||
| Human serum albumin complexed with myristate and 3,5-diiodosalicylic acid | monomer | 100 | 6×MYR; 1×DIU; | |||
| Structure and function of human serum albumin-metal agent complex | monomer | 100 | 7×PLM; 1×8ZR; | |||
| X-ray study of human serum albumin complexed with teniposide | monomer | 100 | 1×9TP; | |||
| HSA-Pt compound complex | monomer | 100 | 6×PLM; 1×ZJZ; | |||
| Human serum albumin with cyclic peptide dalbavancin | monomer | 100 | 2×JEF; 1×F8F; 1×M12; 1×MAN; | |||
| Human serum albumin-Palmitic acid-Fe(Hn3piT)Cl2 | monomer | 100 | 1×6WF; 6×PLM; | |||
| HSA-In agent complex | monomer | 100 | 6×PLM; 1×7Q8; | |||
| lauric acid functionalized hexamolybdoaluminate bound to human serum albumin | monomer | 100 | 6×MYR; 2×M6O; | |||
| HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI-IODOBENZOIC ACID | monomer | 100 | 5×MYR; 2×B3I; | |||
| Cryogenic electron microscopy structure of human serum albumin in complex with teniposide | monomer | 100 | 1×9TP; | |||
| Cryogenic electron microscopy structure of apo human serum albumin | monomer | 100 | ||||
| Cryogenic electron microscopy structure of human serum albumin in complex with salicylic acid | monomer | 100 | 3×SAL; | |||
| Crystal structure of Human Serum Albumin in the presence of 0.5 mM zinc at pH 9.0 | monomer | 100.0 | 1×ZN; 2×UNL; | |||
| X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD, … | monomer | 100 | ||||
| Human Serum Albumin | monomer | 100.0 | ||||
| Human Serum Albumin_1 | monomer | 100.0 | ||||
| Crystal structure of the HSA complex with ceftriaxone and myristate | monomer | 100.0 | 1×9F2; 5×MYR; | |||
| Human Serum Albumin, complexed with Sulfasalazine | monomer | 100.0 | 2×DMS; 1×SO4; 3×SAS; | |||
| Human Serum Albumin_2 | monomer | 100.0 | ||||
| Structure of Human Serum Albumin | monomer | 100 | ||||
| Crystal structure of the HSA complex with cefazolin and myristate | monomer | 100.0 | 1×X56; 3×MYR; | |||
| Human serum albumin (apo form) | monomer | 99.82 | 1×PO4; | |||
| Crystal structure of lysophosphatidylcholine in complex with human serum albumin and myristate | monomer | 99.83 | 3×MYR; 3×LPC; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN | monomer | 100 | 6×MYR; 1×HEM; | |||
| HSA Ligand Free | monomer | 100 | ||||
| Crystal structure of human serum albumin complexed with the general anesthetic propofol | monomer | 100 | 2×PFL; | |||
| High-resolution Crystal Structural Variance Analysis between Recombinant and Wild-type Human Serum … | monomer | 100 | ||||
| High-resolution Crystal Structural Variance Analysis between Recombinant and Wild-type Human Serum … | monomer | 100 | ||||
| Human serum albumin complexed with 3-carboxy-4-methyl-5-propyl-2- furanpropanoic acid (CMPF) | monomer | 100.0 | 2×C1F; | |||
| Crystal structure of human serum albumin complexed with the general anesthetic halothane | monomer | 100 | 3×HLT; | |||
| X-ray study of human serum albumin complexed with camptothecin | monomer | 100 | 1×EHF; | |||
| Human serum albumin complexed with dansyl-L-phenylalanine | monomer | 100.0 | 2×9NF; | |||
| HSA-glucose complex | monomer | 100 | 1×GLO; 1×GLC; 1×PO4; | |||
| CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN | monomer | 100 | ||||
| CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN | monomer | 100 | ||||
| Human serum albumin complexed with dansyl-L-norvaline | monomer | 100.0 | 1×9NV; | |||
| Human serum albumin in complex with compound 3 | monomer | 100 | 1×IQX; | |||
| Crystal structure of human serum albumin | monomer | 100 | ||||
| Human serum albumin complexed with ibuprofen | monomer | 100 | 2×IBP; | |||
| Human serum albumin complexed with azapropazone | monomer | 100 | 2×AZQ; | |||
| Human serum albumin in complex with compound 1 | monomer | 100 | 2×IMX; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID | monomer | 100.0 | 4×IO3; | |||
| Human serum albumin in complex with compound 2 | monomer | 100 | 1×IPX; 3×PO4; | |||
| X-ray study of human serum albumin complexed with idarubicin | monomer | 100 | 2×DM5; | |||
| Crystal structure of HSA-Myr complex soaked with cisplatin for one week | monomer | 100.0 | 9×CPT; 6×MYR; | |||
| Human serum albumin complexed with dansyl-L-sarcosine | monomer | 100.0 | 1×9DS; | |||
| Human serum albumin complexed with diazepam | monomer | 100 | 1×DZP; | |||
| Human serum albumin complexed with diflunisal | monomer | 100.0 | 3×1FL; | |||
| Human serum albumin complexed with warfarin | monomer | 100 | 1×RWF; | |||
| Human serum albumin complexed with phenylbutazone | monomer | 100 | 1×P1Z; | |||
| Human serum albumin complexed with oxyphenbutazone | monomer | 100 | 1×OPB; | |||
| Structural studies of human serum albumin using cryo-EM up to 0.38 nm resolution | monomer | 100 | ||||
| Human Serum albumin with bound Sulfate | monomer | 100 | 1×SO4; | |||
| Human serum albumin complexed with 4Z,15E-bilirubin-IX-alpha | monomer | 100.0 | 1×BLA; | |||
| Human serum albumin complexed with dansyl-L-asparagine | monomer | 100.0 | 2×9DN; | |||
| HSA-fructose complex | monomer | 100.0 | 1×FRU; 1×PO4; 1×FUD; | |||
| HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) | monomer | 99.82 | 4×T44; | |||
| Crystal structure of HSA soaked with cisplatin for one week | monomer | 100.0 | 5×CPT; 1×PO4; | |||
| Human serum albumin complexed with sodium 4-phenylbutyrate | monomer | 100 | 1×CLT; 1×PO4; | |||
| Human serum albumin mutant r218p complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine) | monomer | 99.82 | 4×T44; | |||
| Human serum albumin complexed with octanoate and N-acetyl-L-methionine | monomer | 100 | 1×AME; 2×OCA; 1×PO4; | |||
| Human serum albumin complexed with aripiprazole | monomer | 100.0 | 1×9SC; 1×PO4; 1×K; | |||
| Human serum albumin complexed with benzbromarone | monomer | 100.0 | 4×R75; | |||
| Structure of a Mcl-1 Inhibitor Binding to Site 3 of Human Serum Albumin | monomer | 100 | 1×6AK; 1×PO4; | |||
| Human Serum Albumin Complex with Perfluorooctane Sulfonate Potassium | monomer | 100.0 | 2×P8S; | |||
| Human serum albumin complexed with fusidic acid | monomer | 100.0 | 2×FUA; | |||
| X-ray structure of human serum albumin complexed with cisplatin | monomer | 100.0 | 5×CPT; | |||
| HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) | monomer | 100.0 | 4×T44; | |||
| Crystal structure of the HSA complex with mycophenolate and aripiprazole | monomer | 100.0 | 1×9SC; 1×MOA; | |||
| Human serum albumin complex with deschloro-aripiprazole | monomer | 100.0 | 1×AJW; 2×PO4; | |||
| Human serum albumin complexed with indoxyl sulfate | monomer | 100 | 2×IOS; | |||
| Solution structure of domain 3 from human serum albumin complexed to an anti-apoptotic ligand direc… | monomer | 100 | 1×4EB; | |||
| Three dimensional structure of EPI-X4, a human albumin-derived peptide that regulates innate immuni… | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8rgk.2.A | monomer | 0.83 | 1×GOQ; 6×MYR; | 100.00 | ||
3 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 1n5u.1.A | monomer | 0.80 | 3×MYR; | 96.21 | ||
| Isoform 3 | 8rgk.2.A | monomer | 0.75 | 2×MYR; | 100.00 | ||
| Isoform 3 | 8rcp.2.A | monomer | 0.67 | 2×MYR; | 71.70 | ||